ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma

NCT01997840 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

103

Enrollment

INDUSTRY

Sponsor class

Stopped Change in business priorities.

Conditions

Multiple Myeloma

Interventions

DRUG: ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone

Sponsor

Celgene